Literature DB >> 18714671

Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells.

Jannette M Dufour1, Brinda Dass, Katie R Halley, Gregory S Korbutt, Doreen E Dixon, Ray V Rajotte.   

Abstract

Sertoli cells are important for maintenance of the immune privileged environment of the testis and prolong survival of cotransplanted cells. The objective of the current study was to examine the immunoprotective properties of a mouse Sertoli cell line (MSC-1) in order to identify a Sertoli cell line that could be used to aid in investigation of the immunoprotective abilities of Sertoli cells. BALB/c islets were cotransplanted with 0-9 million primary BALB/c Sertoli cells or MSC-1 cells into diabetic C3H or BALB/c mice and protection of grafted islets was examined by monitoring blood glucose levels and immunohistochemical analysis. Additionally, expression of potential immunoprotective factors in MSC-1 cells was examined. Cotransplantation of islets with 3 million primary Sertoli cells significantly prolonged islet allograft survival (61.1 +/- 6.9 days; p < 0.05) compared with control mice that received allogeneic islets alone (26.9 +/- 2.1 days). Grafts collected from normoglycemic C3H mice at 100 days posttransplant contained insulin-positive beta-cells adjacent to allogeneic Sertoli cells arranged in tubule-like structures. In contrast, cotransplantation of islet allografts with MSC-1 cells did not prolong islet survival (average 29.8 +/- 3.3 days) regardless of the number of MSC-1 cells transplanted and the rejected grafts contained very few beta-cells and randomly arranged MSC-1 cells. The lack of islet cell survival was not due to detrimental effects of MSC-1 cells because syngneic islets cotransplanted with MSC-1 cells were functional throughout the study. MSC-1 cells were found to express known Sertoli cell-expressed, immunoprotective factors, clusterin, Fas ligand, and transforming growth factor-beta1, suggesting additional factors may be involved in Sertoli cell immune privilege. These data indicate the MSC-1 cell line lacks the immunoprotective properties associated with primary Sertoli cells. Further study of this cell line could be useful in examining the mechanisms that enable Sertoli cells to provide immune privilege.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714671     DOI: 10.3727/096368908785096033

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  25 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 2.  Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.

Authors:  Yan-Ho Cheng; Elissa Wp Wong; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

3.  Characterization and functionality of proliferative human Sertoli cells.

Authors:  Kitty Chui; Alpa Trivedi; C Yan Cheng; Diana B Cherbavaz; Paul F Dazin; Ai Lam Thu Huynh; James B Mitchell; Gabriel A Rabinovich; Linda J Noble-Haeusslein; Constance M John
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

Review 4.  The blood-testis and blood-epididymis barriers are more than just their tight junctions.

Authors:  Payal Mital; Barry T Hinton; Jannette M Dufour
Journal:  Biol Reprod       Date:  2011-01-05       Impact factor: 4.285

5.  Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance.

Authors:  Kenneth S K Tung; Jessica Harakal; Hui Qiao; Claudia Rival; Jonathan C H Li; Alberta G A Paul; Karen Wheeler; Patcharin Pramoonjago; Constance M Grafer; Wei Sun; Robert D Sampson; Elissa W P Wong; Prabhakara P Reddi; Umesh S Deshmukh; Daniel M Hardy; Huanghui Tang; C Yan Cheng; Erwin Goldberg
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

Review 6.  Sertoli cells--immunological sentinels of spermatogenesis.

Authors:  Gurvinder Kaur; Lea Ann Thompson; Jannette M Dufour
Journal:  Semin Cell Dev Biol       Date:  2014-03-03       Impact factor: 7.727

Review 7.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

Review 8.  New insights into FAK function and regulation during spermatogenesis.

Authors:  N Ece Gungor-Ordueri; Dolores D Mruk; Hin-ting Wan; Elissa W P Wong; Ciler Celik-Ozenci; Pearl P Y Lie; C Yan Cheng
Journal:  Histol Histopathol       Date:  2014-02-27       Impact factor: 2.303

Review 9.  Characterization of rodent Sertoli cell primary cultures.

Authors:  Helena D Zomer; Prabhakara P Reddi
Journal:  Mol Reprod Dev       Date:  2020-08-02       Impact factor: 2.609

10.  Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.

Authors:  Francesca Fallarino; Giovanni Luca; Mario Calvitti; Francesca Mancuso; Claudio Nastruzzi; Maria C Fioretti; Ursula Grohmann; Ennio Becchetti; Anne Burgevin; Roland Kratzer; Peter van Endert; Louis Boon; Paolo Puccetti; Riccardo Calafiore
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.